Quality of life improvements following eltrombopag treatment in children with chronic immune thrombocytopenia: Case report
The present case series described six chronic immune thrombocytopenia patients (cITP), with a median age of 7.7 (7.0 to 13.0) years and low platelet count at 15,500 (7,000 to 20,000)/uL. They were suffering from bleeding symptoms and side effects of treatment. After enrollment, they were treated wit...
Saved in:
Main Authors: | Nongnuch Sirachainan, Pakawan Wongwerawattanakoon, Duantida Songdej, Ampaiwan Chuansumrit, Surapong Lertthammakiat |
---|---|
Other Authors: | Faculty of Medicine Ramathibodi Hospital, Mahidol University |
Format: | Article |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/78299 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Intramuscular anti-D in chronic immune thrombocytopenia children with severe thrombocytopenia
by: Nongnuch Sirachainan, et al.
Published: (2018) -
Eltrombopag in patients with chronic immune thrombocytopenia in Asia-Pacific, the Middle East, and Turkey: final analysis of CITE
by: Wong R.S.M.
Published: (2023) -
Benefits of prophylactic emicizumab in enhancing immune tolerance induction in a boy with hemophilia A and very high inhibitor titer
by: Nongnuch Sirachainan, et al.
Published: (2022) -
Reticulocyte hemoglobin equivalent in a thalassemia-prevalent area
by: Praguywan Kadegasem, et al.
Published: (2020) -
Combined chelation therapy with daily oral deferiprone and twice-weekly subcutaneous infusion of desferrioxamine in children with β-thalassemia: 3-year experience
by: Duantida Songdej, et al.
Published: (2018)